Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 11325
TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607605(US11691960, Example WO2005/111014 Ex. 4)
Affinity DataIC50: 8nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607603(US11691960, Example WO2005/111029 Ex. 28)
Affinity DataIC50: 26nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607602(US11691960, Example WO2005/111029 Ex. 8)
Affinity DataIC50: 40nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607591(US11691960, Example WO2006/034822 | 5-ethynyl-N-(3...)
Affinity DataIC50: 48nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetAndrogen receptor(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607601(US11691960, Example WO98/22432 example 86)
Affinity DataIC50: 88nMAssay Description:Determination of In Vitro Pharmacological Activity. The human androgen receptor (AR) assay was run using Product #IB03001 from Indigo Biosciences. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetAndrogen receptor(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607600(US11691960, Example WO98/22432 example 53)
Affinity DataIC50: 353nMAssay Description:Determination of In Vitro Pharmacological Activity. The human androgen receptor (AR) assay was run using Product #IB03001 from Indigo Biosciences. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607604(US11691960, Example WO2005/111013 Ex. 22)
Affinity DataIC50: 429nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetAndrogen receptor(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607592(US11691960, Example 1)
Affinity DataIC50: 657nMAssay Description:Determination of In Vitro Pharmacological Activity. The human androgen receptor (AR) assay was run using Product #IB03001 from Indigo Biosciences. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetAndrogen receptor(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607594(US11691960, Example 3)
Affinity DataIC50: 859nMAssay Description:Determination of In Vitro Pharmacological Activity. The human androgen receptor (AR) assay was run using Product #IB03001 from Indigo Biosciences. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607596(US11691960, Example 5)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607595(US11691960, Example 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607594(US11691960, Example 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607593(US11691960, Example 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607592(US11691960, Example 1)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607596(US11691960, Example 5)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607595(US11691960, Example 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607594(US11691960, Example 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607595(US11691960, Example 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607594(US11691960, Example 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607593(US11691960, Example 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607592(US11691960, Example 1)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607593(US11691960, Example 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607592(US11691960, Example 1)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607596(US11691960, Example 5)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607599(US11691960, Example WO2007/003536 Ex. 159)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607598(US11691960, Example WO2007/003536 Ex. 6)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607597(US11691960, Example WO2007/003536 Ex. 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607596(US11691960, Example 5)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607595(US11691960, Example 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607594(US11691960, Example 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607593(US11691960, Example 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607592(US11691960, Example 1)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607596(US11691960, Example 5)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetAndrogen receptor(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607596(US11691960, Example 5)
Affinity DataIC50: 1.00E+4nMAssay Description:Determination of In Vitro Pharmacological Activity. The human androgen receptor (AR) assay was run using Product #IB03001 from Indigo Biosciences. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetAndrogen receptor(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607595(US11691960, Example 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Determination of In Vitro Pharmacological Activity. The human androgen receptor (AR) assay was run using Product #IB03001 from Indigo Biosciences. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetAndrogen receptor(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607593(US11691960, Example 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Determination of In Vitro Pharmacological Activity. The human androgen receptor (AR) assay was run using Product #IB03001 from Indigo Biosciences. Th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607595(US11691960, Example 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607594(US11691960, Example 3)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607593(US11691960, Example 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent

TargetCoagulation factor X(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM607592(US11691960, Example 1)
Affinity DataIC50: 1.00E+4nMAssay Description:Measurement of active human Factor Xa using a specific chromogenic substrate which is labeled with a p-nitro-anilino group (pNA). The cleavage in bet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
US Patent